These results suggest that AGNE suppressed inflammatory responses in AD by reducing the secretion of inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 blocking the NF-κB pathway. Here, NFKB1 is linked to Alzheimer disease.